Application of Ultrasound in Assessment of Biologics Efficacy in Patients with Rheumatoid Arthritis.
作者信息
Chen Yen-Ju, Lai Kuo-Lung
机构信息
Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
出版信息
J Med Ultrasound. 2022 Jan 6;30(2):79-80. doi: 10.4103/JMU.JMU_147_21. eCollection 2022 Apr-Jun.
Abstract
摘要
相似文献
1
Application of Ultrasound in Assessment of Biologics Efficacy in Patients with Rheumatoid Arthritis.
J Med Ultrasound. 2022 Jan 6;30(2):79-80. doi: 10.4103/JMU.JMU_147_21. eCollection 2022 Apr-Jun.
2
[Role of diagnostic ultrasound in assessment of disease activity in rheumatoid arthritis].
Reumatizam. 2012;59(2):140-4.
3
Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden.
BMJ. 2016 Jan 28;352:i262. doi: 10.1136/bmj.i262.
4
Tapering Biologic Therapy for Rheumatoid Arthritis: A Qualitative Study of Patient Perspectives.
Patient. 2020 Apr;13(2):225-234. doi: 10.1007/s40271-019-00403-9.
5
[Biologics and mycobacterial diseases].
Kekkaku. 2013 Mar;88(3):337-53.
6
[Perspective of ultrasound-guided strategy to reduce/discontinue biologics].
Nihon Rinsho. 2016 Jun;74(6):919-23.
7
Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids.
Mod Rheumatol. 2022 Apr 18;32(3):522-527. doi: 10.1093/mr/roab026.
8
Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims.
Clin Ther. 2014 Jul 1;36(7):996-1004. doi: 10.1016/j.clinthera.2014.05.062. Epub 2014 Jul 8.
9
The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence.
Curr Opin Rheumatol. 2007 May;19(3):308-13. doi: 10.1097/01.bor.0000265447.48722.04.
10
Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series.
Mod Rheumatol. 2015 Sep;25(5):794-7. doi: 10.3109/14397595.2013.844389. Epub 2015 Jul 29.
本文引用的文献
1
Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis.
Lancet. 2015 Jul 18;386(9990):258-65. doi: 10.1016/S0140-6736(14)61704-9. Epub 2015 May 11.
2
Subclinical inflammation on MRI of hand and foot of anticitrullinated peptide antibody-negative arthralgia patients at risk for rheumatoid arthritis.
Arthritis Res Ther. 2014 Apr 10;16(2):R92. doi: 10.1186/ar4536.
3
Early aggressive intervention with tocilizumab for rheumatoid arthritis increases remission rate defined using a Boolean approach in clinical practice.
Mod Rheumatol. 2012 Jun;22(3):370-5. doi: 10.1007/s10165-011-0528-2. Epub 2011 Sep 20.
4
Ultrasonography shows significant improvement in wrist and ankle tenosynovitis in rheumatoid arthritis patients treated with adalimumab.
Scand J Rheumatol. 2011 May;40(3):178-82. doi: 10.3109/03009742.2010.517549. Epub 2010 Nov 23.
5
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Arthritis Rheum. 2010 Sep;62(9):2569-81. doi: 10.1002/art.27584.
6
Rheumatoid arthritis.
Lancet. 2010 Sep 25;376(9746):1094-108. doi: 10.1016/S0140-6736(10)60826-4.
7
Musculoskeletal ultrasound including definitions for ultrasonographic pathology.
J Rheumatol. 2005 Dec;32(12):2485-7.
Zotero 插件